NOW vs PFE: Which Is the Better Buy?

Side-by-side comparison of ServiceNow, Inc. and Pfizer Inc. — fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-07-18.
ServiceNow, Inc. · Technology
$103.24
+45.0% upside to fair value
Grade B High Quality
VS
Pfizer Inc. · Healthcare
$25.22
+2.8% upside to fair value
Grade B
QuantHub Verdict
NOW has more upside to fair value (+45.0%). PFE trades at a lower forward P/E (19.2x). These are model outputs — not personalized investment advice. See all research →
Valuation & Fundamentals
Metric NOW PFE
Current Price $103.24 $25.22
Fair Value Estimate $149.70 $25.92
Upside to Fair Value +45.0% +2.8%
Market Cap $106.5B $143.7B
Forward P/E 61.1x 19.2x
EV / EBITDA 32.9x 12.3x
Price / Sales 7.6x 2.3x
Price / FCF 23.0x 15.2x
Revenue Growth YoY +22.1% +5.4%
Gross Margin 76.6% 69.3%
Operating Margin 13.4% 23.4%
Return on Equity 15.0% 8.4%
Dividend Yield 0% 0%
FCF Yield 4.35% 6.6%
Analyst Consensus Strong Buy Hold
Investment Thesis
NOW — ServiceNow, Inc.
ServiceNow, Inc. operates in the technology sector specializing in software applications, delivering high-quality enterprise cloud solutions with a durable competitive moat evidenced by a 15% return on equity and strong gross margins of 76.6%. The company is currently in an investing growth phase with 22.1% revenue growth in the most recent quarter, although earnings growth is modest at 2.0%. Des…
PFE — Pfizer Inc.
Pfizer Inc. is a leading global biopharmaceutical company with a diversified portfolio dominated by its Biopharma prescription segment, which accounts for over 90% of revenue. The company benefits from a substantial scale, a broad product portfolio including top-selling drugs like Eliquis, Prevnar, and Paxlovid, and a strong manufacturing footprint. However, Pfizer faces challenges from declining…
Accumulation Zones
Metric NOW PFE
Zone Low $112.27 $19.44
Zone High $127.24 $22.03
In Buy Zone? Yes No
← NOW Research    PFE Research →    All Research